In our experiments with the compound piperlongumine, we treated cancer cells with an amount of drug previously shown to induce elevation of cytosolic H2O2 that was essential to toxicity over a 48 h period14 and observed a significant increase the emission ratio of our probe, which was reversible upon over-expression of catalase in the cytosol. The gene discussed is CAT; the disease is cancer.